Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIODESIX INC Director's Dealing 2024

Apr 3, 2024

34472_dirs_2024-04-03_e98a7a14-a554-4100-97e1-eb74046f1b43.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIODESIX INC (BDSX)
CIK: 0001439725
Period of Report: 2024-04-01

Reporting Person: Watts Charles M (N/A)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2024-04-01 Common Stock M 134262 Acquired 348651 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2024-04-01 Restricted Stock Units $ M 134262 Disposed Common Stock (134262) Direct

Footnotes

F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.

F2: These RSUs vested in full on March 31, 2024, and had no expiration date.